Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021)

Minerva Neurosciences (NERV) reported Other Non-Current Assets of $14808.0 for Q2 2021, little changed on a YoY basis from $14808.0 in Q2 2020, and little changed quarter-over-quarter from $14808.0 in Q1 2021.

Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021) Analysis & Trends

Minerva Neurosciences has reported Other Non-Current Assets for 7 years, with the latest figure at $14808.0 in Q2 2021.

  • For the quarter ending Q2 2021, Other Non-Current Assets changed 0.0% year-over-year to $14808.0; the trailing twelve-month figure through Jun 2021 stood at $14808.0 (changed 0.0% YoY), and the FY2020 full-year result was $14808.0, changed 0.0% from the prior year.
  • Other Non-Current Assets for Q2 2021 stood at $14808.0, roughly flat from $14808.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $14808.0 in Q4 2017, with the low at $14808.0 in Q4 2017.
  • Historically, Other Non-Current Assets has averaged $14808.0 across 5 years, with a median of $14808.0 in 2017.
  • The largest YoY upside for Other Non-Current Assets was 0.0% in 2018 against a maximum downside of 0.0% in 2018.
  • Minerva Neurosciences' Other Non-Current Assets stood at $14808.0 in 2017, then changed by 0.0% to $14808.0 in 2018, then changed by 0.0% to $14808.0 in 2019, then changed by 0.0% to $14808.0 in 2020, then changed by 0.0% to $14808.0 in 2021.
  • The last three Other Non-Current Assets figures came in at $14808.0 (Q2 2021), $14808.0 (Q1 2021), and $14808.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Minerva Neurosciences 197.55 Mn 197.55 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 14,808.00
Mar 31, 2021 14,808.00
Dec 31, 2020 14,808.00
Sep 30, 2020 14,808.00
Jun 30, 2020 14,808.00
Mar 31, 2020 14,808.00
Dec 31, 2019 14,808.00
Sep 30, 2019 14,808.00
Jun 30, 2019 14,808.00
Mar 31, 2019 14,808.00
Dec 31, 2018 14,808.00
Sep 30, 2018 14,808.00
Jun 30, 2018 14,808.00
Mar 31, 2018 14,808.00
Dec 31, 2017 14,808.00
Jun 30, 2014 3.11 Mn
Dec 31, 2013 433,998.00